求助7篇文献 不胜感激

aaaszw

: h  X1 O* H1 Z$ g# d
7 ]5 u" H3 L2 wTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.# n, V" D5 q, l9 T* c2 P
https://www.ncbi.nlm.nih.gov/pubmed/27912061
) B6 x# a0 T1 R. A
5 X0 D0 R. ^, lThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.+ K' m: `( j) Z/ C8 ^
https://www.ncbi.nlm.nih.gov/pubmed/27525555& d5 T: O/ y2 O$ U% P5 e

( y) H0 d& O( D  uBioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion
& T" A8 u! V2 nhttps://www.ncbi.nlm.nih.gov/pubmed/27496729
2 \  J" P. O  G: G4 Q, X* w, u1 U0 z4 R: ~9 t0 ?% j& V- d& T
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.5 f1 G% Y7 n8 i6 u0 p
https://www.ncbi.nlm.nih.gov/pubmed/27430722( _% b5 D( J2 s& N# N
& [: y/ s$ ]) l- F1 Y
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
! `3 o# R: i! n' Q1 a# _https://www.ncbi.nlm.nih.gov/pubmed/27192569
" h. k1 k- k9 R
. S' X* n5 ~7 c) lCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling1 [" _* s6 \, p- w! Y. G. D
https://www.ncbi.nlm.nih.gov/pubmed/27058661- Y0 z# q( ^3 E7 Y$ w( W( _) {
( s2 C8 T# X# o3 T, h1 b
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
, t& `# C0 w' D/ r: Fhttps://www.ncbi.nlm.nih.gov/pubmed/27036972

lchanlon

回复 aaaszw 的帖子
. ]+ T) E. z1 H! ~
6 _4 k/ J9 B& `& aHere you go
0 I- g9 }! o: d% _1 L0 a" \' d  B5 p6 ~# f5 \) H3 n# X7 r. E
Good luck!

lchanlon

回复 aaaszw 的帖子
7 Y7 b% [/ U% G; c
: n) l  W7 J7 ~1 eHere you go
" V2 M( p( T& d' q7 @
4 n/ z; i. k+ M) iGood luck!

aaaszw

回复 lchanlon 的帖子
0 L4 _% J9 G1 `0 x+ a# B  B' e& v% e+ c: k; S( ^
merci beaucoup ：）